Results for tag: "Neuromuscular Disease"

The Neuromuscular Disease market is a subset of the Neurology market, focusing on diseases that affect the muscles and the nerves that control them. These diseases can range from mild to severe, and can be caused by genetic mutations, autoimmune disorders, or environmental factors. Treatment options vary depending on the type of disease, and can include physical therapy, medications, and in some cases, surgery. The Neuromuscular Disease market is highly competitive, with many companies offering treatments and therapies. Some of these companies include Biogen, Novartis, Sanofi, AbbVie, and Pfizer. Show Less Read more